1. Home
  2. TRVI vs GIII Comparison

TRVI vs GIII Comparison

Compare TRVI & GIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

HOLD

Current Price

$10.15

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo G-III Apparel Group LTD.

GIII

G-III Apparel Group LTD.

HOLD

Current Price

$28.72

Market Cap

1.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRVI
GIII
Founded
2011
1956
Country
United States
United States
Employees
N/A
4600
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2019
1989

Fundamental Metrics

Financial Performance
Metric
TRVI
GIII
Price
$10.15
$28.72
Analyst Decision
Strong Buy
Hold
Analyst Count
12
5
Target Price
$20.38
$31.20
AVG Volume (30 Days)
1.3M
346.7K
Earning Date
03-17-2026
03-12-2026
Dividend Yield
N/A
1.40%
EPS Growth
N/A
N/A
EPS
N/A
3.27
Revenue
N/A
$3,025,059,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$8.75
Revenue Growth
N/A
N/A
52 Week Low
$3.73
$20.33
52 Week High
$14.39
$34.83

Technical Indicators

Market Signals
Indicator
TRVI
GIII
Relative Strength Index (RSI) 34.14 42.73
Support Level $10.17 $28.29
Resistance Level $11.15 $29.86
Average True Range (ATR) 0.73 1.10
MACD -0.13 -0.15
Stochastic Oscillator 3.52 11.17

Price Performance

Historical Comparison
TRVI
GIII

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About GIII G-III Apparel Group LTD.

G-III Apparel Group Ltd is a textile company. It makes a wide range of apparel, footwear, and accessories that it sells under its own brands, licensed brands, and private-label brands. G-III has a substantial portfolio for licensed and proprietary brands, anchored by five global power brands: DKNY, Donna Karan, Calvin Klein, Tommy Hilfiger, and Karl Lagerfeld. The company has two reportable operations: Wholesale Operations and Retail Operations. The Wholesale operations segment includes sales of products under brands licensed by from third parties, as well as sales of products under its own brands and private label brands. The retail operations segment consists of Wilsons Leather, G.H. Bass, and DKNY retail stores. It derives majority of its revenues from Wholesale operations.

Share on Social Networks: